Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

WELLAND - Ontario’s police watchdog is investigating after a 26-year-old man was shot and killed by police in Welland. Investigators said tactical members of the Niagara Regional Police Service ...

Health editor Michael Smith on CSL’s remarkable story, why investors have fallen out of love with the healthcare giant and what Trump has to do with it. CSL was run like a bureaucracy until 1990 when ...

US vaccination forecast leads to fall in stock price, while board survives spill in ‘second strike’ over pay concerns at AGM Follow our Australia news live blog for latest updates Get our breaking ...

CSL (ASX:CSL) has attracted fresh attention after its Broadmeadows plasma fractionation facility in Australia was named the Overall Winner of the 2025 Facility of the Year Award by the International ...

(Reuters) -Australian biotech CSL said on Tuesday it no longer expects to complete the spin-off of its vaccine division in fiscal 2026, citing heightened volatility in the U.S. influenza vaccine ...

A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...

CSL has partnered with Dutch biotech VarmX to co-develop VMX-C001, a potential first-in-class treatment to restore blood coagulation in patients on FXa inhibitors. The agreement includes an upfront ...

Nearly 15 per cent of CSL’s global workforce will be reduced in the biggest shake-up of the company in decades aimed at “simplifying the business”. CSL employs about 30,000 staff globally. Its share ...

Plans to spin off CSL Seqirus into listed entity by next June Seeks annualised savings of up to $550 million over three years Lifts dividend and plans A$750 million share buyback Underlying profit up ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...

Thank you for standing by, and welcome to the CSL Limited Full Year Financial Results. [Operator Instructions] I would now like to hand the conference over to Mr. Chris Cooper, Head of Investor ...